Two hits are better than one: synergistic anticancer activity of α-helical peptides and doxorubicin/epirubicin

This study explored combinational anticancer therapy using α-helical peptides HPRP-A1/HPRP-A2 with the chemical drugs doxorubicin (DOX) and epirubicin (EPI). The in vitro activity of these drugs against different cancer cell lines was synergistically increased, as was their activity in a HeLa xenogr...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Zhao, Jing, Huang, Yibing, Liu, Dong, Chen, Yuxin
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2014
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359330/
https://ncbi.nlm.nih.gov/pubmed/25593197
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items